Medical Education Library

Updates in MS: Highlights From the ECTRIMS and ACTRIMS Annual Meetings

Publish date: April 11, 2018

This supplement to Neurology Reviews includes highlights from the Fall 2017 ECTRIMS meeting, plus highlights from the Winter 2018 ACTRIMS meeting.

 

Read the digital edition here.

Recommended Reading

Natalizumab May Be Associated With Increased Disease Activity During Pregnancy
MDedge Neurology
Are Complementary and Alternative Treatments Effective for MS?
MDedge Neurology
Frankincense extract may reduce disease activity in relapsing-remitting MS
MDedge Neurology
Extended-Interval Dosing of Natalizumab Is Associated With Reduced PML Risk
MDedge Neurology
MicroRNA Could Be a Biomarker of MS
MDedge Neurology
Patients With MS May Not Receive Appropriate Medicines From Primary Care Doctors
MDedge Neurology
What Is the Mechanism of Alemtuzumab-Induced Autoimmunity?
MDedge Neurology
High Dose of Novel Compound Shows Promise for Relapsing-Remitting MS
MDedge Neurology
Clean-Surfaced Nanocrystalline Gold May Promote Remyelination
MDedge Neurology
Ari Green, MD
MDedge Neurology